financing

News

In another sign of recovery in digital health investing, Omada Health has priced an IPO that could value the company at more than $1.1 billion.

News

Brain-computer interface firm Neuralink has completed a $650m financing that it says will help to "bring our technology to more people."

News

Our round-up of recent biotech financings includes rounds for GRIN Therapeutics, GlycoEra, Syndeio, Juvenescence, and Vima Therapeutics.

News

In a signal of a return to investor appetite for digital health stocks, Hinge Health has raised an impressive $437 million in an IPO.

News

Our round-up of recent biotech financings includes rounds for Pathos AI, Stylus Medicine, Haya Therapeutics, Therini Bio and Tiltbio.

News

Azafaros is set to start phase 3 trials of its lead drug for a trio of rare lysosomal storage disorders, backed by €132m in new Series B financing.